BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24439556)

  • 1. [Adult patients treated for focal epilepsy with antiepileptic drugs (AEDs) in combination in France: description according to the 2009 ILAE definition of AED resistance (ESPERA study)].
    Vespignani H; de Zélicourt M; Laurendeau C; Fagnani F; Levy-Bachelot L; Murat C; Kahane P; de Toffol B
    Rev Neurol (Paris); 2014 Feb; 170(2):100-9. PubMed ID: 24439556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of focal epilepsy in adults treated with polytherapy in France: the direct cost of drug resistance (ESPERA study).
    de Zélicourt M; de Toffol B; Vespignani H; Laurendeau C; Lévy-Bachelot L; Murat C; Fagnani F
    Seizure; 2014 May; 23(5):349-56. PubMed ID: 24560531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESPERA study: applicability of the new ILAE criteria for antiepileptic drug resistance of focal epilepsies in current clinical practice.
    de Toffol B; de Zélicourt M; Vespignani H; Fagnani F; Laurendeau C; Lévy-Bachelot L; Murat C; Gasalla T; Arzimanoglou A; Villanueva V
    Epilepsy Behav; 2012 Oct; 25(2):166-9. PubMed ID: 23032124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
    Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
    Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do neurologists agree in diagnosing drug resistance in adults with focal epilepsy?
    Zaccara G; Mula M; Ferrò B; Consoli D; Elia M; Giallonardo AT; Iudice A; La Neve A; Meletti S; Tinuper P; Zummo L; Perucca E
    Epilepsia; 2019 Jan; 60(1):175-183. PubMed ID: 30585315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
    Groth A; Wilke T; Borghs S; Gille P; Joeres L
    Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.
    Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E;
    Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validated outcome of treatment changes according to International League Against Epilepsy criteria in adults with drug-resistant focal epilepsy.
    Mula M; Zaccara G; Galimberti CA; Ferrò B; Canevini MP; Mascia A; Mecarelli O; Michelucci R; Pisani LR; Specchio LM; Striano S; Perucca E
    Epilepsia; 2019 Jun; 60(6):1114-1123. PubMed ID: 30866058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study.
    Moavero R; Cusmai R; Specchio N; Fusco L; Capuano A; Curatolo P; Vigevano F
    Epilepsy Res; 2012 Nov; 102(1-2):94-9. PubMed ID: 22677424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal of antiepileptic drugs in young patients with cryptogenic focal epilepsies.
    Pavlović M; Jović N; Pekmezović T
    Seizure; 2012 Jul; 21(6):431-6. PubMed ID: 22621814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dosage failed of first antiepileptic drug on subsequent outcome.
    Brodie MJ; Barry SJ; Bamagous GA; Kwan P
    Epilepsia; 2013 Jan; 54(1):194-8. PubMed ID: 23106423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncontrolled epilepsy is not necessarily the same as drug-resistant epilepsy: differences between populations with newly diagnosed epilepsy and chronic epilepsy.
    Hao X; Goldberg D; Kelly K; Stephen L; Kwan P; Brodie MJ
    Epilepsy Behav; 2013 Oct; 29(1):4-6. PubMed ID: 23911352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of antiepileptic drug combination therapy for partial-onset seizures based on mechanisms of action.
    Margolis JM; Chu BC; Wang ZJ; Copher R; Cavazos JE
    JAMA Neurol; 2014 Aug; 71(8):985-93. PubMed ID: 24911669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Refractory epilepsy: use of the new definition and related risk factors. A study in the Mexican population of a third-level centre].
    Martínez-Juárez IE; López-Zapata R; Gómez-Arias B; Bravo-Armenta E; Romero-Ocampo L; Estévez-Cruz Z; Hernández-De la Cruz G; Morán-Molina S
    Rev Neurol; 2012 Feb; 54(3):159-66. PubMed ID: 22278892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study.
    Villanueva V; Girón JM; Martín J; Hernández-Pastor LJ; Lahuerta J; Doz M; Cuesta M; Lévy-Bachelot L;
    Neurologia; 2013 May; 28(4):195-204. PubMed ID: 22743210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early add-on treatment vs alternative monotherapy in patients with partial epilepsy.
    Semah F; Thomas P; Coulbaut S; Derambure P
    Epileptic Disord; 2014 Jun; 16(2):165-74. PubMed ID: 24776953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?
    Brodie MJ; Kelly K; Stephen LJ
    Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation and duration of antiepileptic drug therapy: a retrospective study of factors for specific epileptic syndromes.
    Kudo T; Nishida T; Yagi K
    Epilepsia; 2004; 45 Suppl 8():26-32. PubMed ID: 15610191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of reimbursement restrictions on the choice of antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET).
    Boon P; Dejonghe P; Legros B; Sadzot B; van Rijckevorsel K; Schmedding E
    Seizure; 2008 Jun; 17(4):350-7. PubMed ID: 18203628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.